Rasheduzzaman Rashu Selected Research

Rasheduzzaman Rashu Research Topics

Disease

12	Cholera 04/2019 - 08/2011
11	Infections 01/2022 - 12/2011
2	Reinfection 01/2020 - 01/2019
2	Diarrhea 01/2018 - 12/2011
2	Typhoid Fever (Typhoid) 11/2017 - 01/2016
1	COVID-19 04/2023
1	Vesicular Stomatitis 04/2023
1	Human Influenza (Influenza) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 05/2022
1	Ovarian Epithelial Carcinoma 05/2022
1	Ascites 05/2022
1	Neoplasms (Cancer) 05/2022
1	Inflammation (Inflammations) 01/2022
1	Bacteremia 01/2016
1	Communicable Diseases (Infectious Diseases) 12/2011

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 01/2018 - 12/2011
6	Cholera Vaccines FDA Link 01/2019 - 08/2012
5	Proteins (Proteins, Gene)FDA Link 04/2023 - 10/2013
5	LipopolysaccharidesIBA 01/2018 - 12/2011
4	VaccinesIBA 04/2023 - 12/2011
4	CytokinesIBA 05/2022 - 08/2011
4	Cholera ToxinIBA 01/2019 - 01/2013
4	AntibodiesIBA 01/2018 - 01/2013
2	LigandsIBA 01/2023 - 05/2022
2	Immunoglobulin G (IgG)IBA 04/2019 - 05/2014
2	EnzymesIBA 01/2018 - 10/2013
2	Immunoglobulin A (IgA)IBA 05/2014 - 12/2011
1	5- (2- oxopropylideneamino)- 6- d- ribitylaminouracilIBA 01/2023
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2023
1	Viral VaccinesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 05/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Semaphorins (Semaphorin)IBA 01/2022
1	Micrococcal NucleaseIBA 01/2021
1	CD40 Ligand (CD40L)IBA 04/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	Dual OxidasesIBA 01/2018
1	InterferonsIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Hemolysin Proteins (Hemolysins)IBA 11/2017
1	Monoclonal AntibodiesIBA 12/2016
1	Neuraminidase (Sialidase)IBA 12/2016
1	Polysaccharides (Glycans)IBA 12/2016
1	MicronutrientsIBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Complementary DNA (cDNA)IBA 01/2016
1	O Antigens (O Antigen)IBA 05/2014
1	Immunoglobulin M (IgM)IBA 05/2014
1	DukoralIBA 10/2013
1	ImmunosorbentsIBA 10/2013
1	N 30IBA 01/2013
1	Lewis Blood Group AntigensIBA 12/2011
1	ABO Blood-Group SystemIBA 12/2011
1	Blood Group Antigens (Blood Groups)IBA 12/2011

Therapy/Procedure

1	Immunotherapy 05/2022
1	Fluid Therapy (Oral Rehydration Therapy) 01/2018